Clinical Trials Browser

Phase 2 × Carcinoma, Islet Cell × temsirolimus × Clear all

NCT00093782 2017-02-07

Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

Phase 2 Completed

36 enrolled 12 charts

Carcinoma, Islet Cell